The role involves designing, conducting, and interpreting the pathology aspects of nonclinical toxicity and pharmacologic studies for drug discovery. The pathologist will provide scientific leadership and represent outcomes to global health authorities to support clinical trials.
Requirements summary
Candidates must hold a DVM or equivalent degree, ACVP certification in Anatomic Pathology, and a PhD in a related science field. Required experience includes 2-10 years of evaluating and reporting GLP and non-GLP pathology data from nonclinical toxicity studies.
professional certificatepostgraduate degreeRegulatory ReportingCross-functional CollaborationPeer ReviewAnatomic PathologyDigital PathologyScientific LeadershipGLP ComplianceTranslational MedicineNonclinical Study DesignToxicity InterpretationPharmacologic Effects AnalysisComparative Medicine
Job description
At Lilly, we unite caring with discovery to make life better for people around the world.
We are a global healthcare leader headquartered in Indianapolis, Indiana.
Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism.
We give our best effort to our work, and we put people first.
We’re looking for people who are determined to make life better for people around the world.
Eli Lilly & Company is seeking a talented and energetic anatomic veterinary pathologist to work in drug discovery and development at the Lilly Corporate Center in Indianapolis, IN.
The individual selected for this position will join a talented group of anatomic and clinical pathologists reporting to the Senior Director of Pathology in the Division of Toxicology and Pathology.
The individual selected should be able to work collaboratively in cross-functional drug discovery and development teams within Lilly and with Lilly’s external partners to provide scientific leadership in interpreting toxicity and pharmacologic effects caused by drugs.
They will be expected to design, conduct, interpret, and peer review the pathology-related aspects of nonclinical studies.
The successful candidate will represent pathology-related outcomes to global health authorities to support clinical trials and marketing authorizations.
A key expectation will be to identify and resolve pathology and toxicology issues affecting the discovery and development of pharmaceuticals.
The role involves frequent interactions with external business partners, particularly as a pathology peer reviewer.
We are seeking an individual with strong communication and engagement skills to partner with a world-class organization of scientists and leverage translational and comparative medicine expertise to positively impact projects in Lilly’s portfolio.
Basic Qualifications: DVM or equivalent degree and certification by the American College of Veterinary Pathologists (ACVP) (Anatomic Pathology) Ph.D. in a related field of science 2 years of experience in evaluating, interpreting, and reporting GLP and non-GLP pathology data from nonclinical toxicity studies Onsite Indianapolis required Additional Skills/Preferences: Experience in pathology peer review of data from GLP nonclinical toxicity studies Experience in the interpretation and/or reporting of clinical pathology data from nonclinical toxicity studies Experience in the evaluation and reporting of pathology data from animal models of human disease or other types of drug discovery studies Experience using digital pathology to evaluate and analyze pathology endpoints Clear and concise oral and written communication, particularly of pathology data Development of scientific and regulatory perspectives on emerging issues and excellent problem-solving skills Ability to work individually or effectively in cross-functional teams on issues related to drug discovery and development Experience working with multiple therapeutic modalities Ability to travel to Lilly business partners and regulatory agencies to conduct Lilly Toxicology and Pathology business Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions.
Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.
Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.
Our employee resource groups (ERGs) offer strong support networks for their members and are open to all employees.
Our current groups include: Africa, Middle East, Central Asia Network, Black Employees at Lilly, Chinese Culture Network, Japanese International Leadership Network (JILN), Lilly India Network, Organization of Latinx at Lilly (OLA), PRIDE (LGBTQ+ Allies), Veterans Leadership Network (VLN), Women’s Initiative for Leading at Lilly (WILL), enAble (for people with disabilities).
Learn more about all of our groups.
Actual compensation will depend on a candidate’s education, experience, skills, and geographic location.
The anticipated wage for this position is $169,500 - $312,400 Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance).
In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees. #WeAreLilly At Lilly we strive to ensure our employees are part of a team that cares about them and our shared purpose of making life better for those around the world.
How do we do this?
We continue to look for ways to include, innovate, accelerate and deliver while maintaining integrity, excellence and respect for people.
We hope that you seek to join us on our journey as we create medicine and deliver improved outcomes for patients across the globe! #WeAreLilly
